Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bonkovsky

Showing results (261-270 of 351) with videos related to

Pageof 36
Sort By:
Gut|August 3, 2010
Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis CRobert J Fontana, Jules L Dienstag, Herbert L Bonkovsky, et al.
Biochemical Pharmacology|June 9, 1992
Porphyrogenic properties of the terpenes camphor, pinene, and thujone (with a note on historic implications for absinthe and the illness of Vincent van Gogh)H L Bonkovsky, E E Cable, J W Cable, et al.
Journal of Inherited Metabolic Disease|September 7, 2022
EXPLORE B: A prospective, long-term natural history study of patients with acute hepatic porphyria with chronic symptomsDavid Cassiman, Raili Kauppinen, Susana Monroy, et al.
The American Journal of the Medical Sciences|April 18, 2021
Biochemical Diagnosis of Acute Hepatic Porphyria: Updated Expert Recommendations for Primary Care PhysiciansKarl E Anderson, Raynah Lobo, Denise Salazar, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 9, 2025
A Prospective, Blinded Study of Symptom Prevalence and Specificity of Porphyrin Precursors in Carriers of Acute Hepatic PorphyriaMohsen Merati, Nanditha Jayakumar, Yuvraaj Kapoor, et al.
Hepatology (Baltimore, Md.)|December 17, 2016
Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplementsHerbert L Bonkovsky, David E Kleiner, Jiezhun Gu, et al.
The American Journal of Cardiology|October 5, 2015
Relation of Pre-anthracycline Serum Bilirubin Levels to Left Ventricular Ejection Fraction After ChemotherapyTrinity Vera, Ralph B D'Agostino, Jennifer H Jordan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 7, 2024
Drug-induced liver injury (DILI) ascribed to non-steroidal anti-inflammatory drugs (NSAIDs) in the USA-Update with genetic correlationsHerbert L Bonkovsky, Marwan Ghabril, Paola Nicoletti, et al.
Alimentary Pharmacology & Therapeutics|January 15, 2010
Changes in quality of life and sexual health are associated with low-dose peginterferon therapy and disease progression in patients with chronic hepatitis CK K Snow, H L Bonkovsky, R J Fontana, et al.
JIMD Reports|November 20, 2019
Evaluating quality of life tools in North American patients with erythropoietic protoporphyria and X-linked protoporphyriaHetanshi Naik, Jessica R Overbey, Robert J Desnick, et al.
Pageof 36

Showing results (261-270 of 351) with videos related to

Sort By:
Pageof 36
Gut|August 3, 2010
Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis CRobert J Fontana, Jules L Dienstag, Herbert L Bonkovsky, et al.
Biochemical Pharmacology|June 9, 1992
Porphyrogenic properties of the terpenes camphor, pinene, and thujone (with a note on historic implications for absinthe and the illness of Vincent van Gogh)H L Bonkovsky, E E Cable, J W Cable, et al.
Journal of Inherited Metabolic Disease|September 7, 2022
EXPLORE B: A prospective, long-term natural history study of patients with acute hepatic porphyria with chronic symptomsDavid Cassiman, Raili Kauppinen, Susana Monroy, et al.
The American Journal of the Medical Sciences|April 18, 2021
Biochemical Diagnosis of Acute Hepatic Porphyria: Updated Expert Recommendations for Primary Care PhysiciansKarl E Anderson, Raynah Lobo, Denise Salazar, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 9, 2025
A Prospective, Blinded Study of Symptom Prevalence and Specificity of Porphyrin Precursors in Carriers of Acute Hepatic PorphyriaMohsen Merati, Nanditha Jayakumar, Yuvraaj Kapoor, et al.
Hepatology (Baltimore, Md.)|December 17, 2016
Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplementsHerbert L Bonkovsky, David E Kleiner, Jiezhun Gu, et al.
The American Journal of Cardiology|October 5, 2015
Relation of Pre-anthracycline Serum Bilirubin Levels to Left Ventricular Ejection Fraction After ChemotherapyTrinity Vera, Ralph B D'Agostino, Jennifer H Jordan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 7, 2024
Drug-induced liver injury (DILI) ascribed to non-steroidal anti-inflammatory drugs (NSAIDs) in the USA-Update with genetic correlationsHerbert L Bonkovsky, Marwan Ghabril, Paola Nicoletti, et al.
Alimentary Pharmacology & Therapeutics|January 15, 2010
Changes in quality of life and sexual health are associated with low-dose peginterferon therapy and disease progression in patients with chronic hepatitis CK K Snow, H L Bonkovsky, R J Fontana, et al.
JIMD Reports|November 20, 2019
Evaluating quality of life tools in North American patients with erythropoietic protoporphyria and X-linked protoporphyriaHetanshi Naik, Jessica R Overbey, Robert J Desnick, et al.
Pageof 36